Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.
Treatment of C57BL/6 mice with one transfusion of BALB/c spleen cells and anti-CD154 (anti-CD40-ligand) antibody permits BALB/c islet grafts to survive indefinitely and BALB/c skin grafts to survive for approximately 50 d without further intervention. The protocol induces long-term allograft surviva...
Spremljeno u:
| Izdano u: | J Clin Invest |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Clinical Investigation
1998
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC508834/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9616216/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI2703 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
